Back to Search Start Over

How does cell‐based non‐invasive prenatal test (NIPT) perform against chorionic villus sampling and cell‐free NIPT in detecting trisomies and copy number variations? A clinical study from Denmark.

Authors :
Hatt, Lotte
Ravn, Katarina
Dahl Jeppesen, Line
Hestbek Nicolaisen, Bolette
Baasch Christensen, Inga
Singh, Ripudaman
Schelde, Palle
Horsholt Thomsen, Simon
Christensen, Rikke
Sinding, Marianne
Vase, Laura
Oestergaard, Marianne
Bender Ruggard, Marie
Jensen, Hanne S.
Mogensen, Helle
Uldbjerg, Niels
Becher, Naja
Markholt, Sara
Sandager, Puk
Henning Pedersen, Lars
Source :
Prenatal Diagnosis; Jun2023, Vol. 43 Issue 7, p854-864, 11p
Publication Year :
2023

Abstract

Objectives: We aimed to compare cell‐based NIPT (cbNIPT) to chorionic villus sampling (CVS) and to examine the test characteristics of cbNIPT in the first clinical validation study of cbNIPT compared to cell‐free NIPT (cfNIPT). Material and Methods: Study 1: Women (N = 92) who accepted CVS were recruited for cbNIPT (53 normal and 39 abnormal). Samples were analyzed with chromosomal microarray (CMA). Study 2: Women (N = 282) who accepted cfNIPT were recruited for cbNIPT. cfNIPT was analyzed using sequencing and cbNIPT by CMA. Results: Study 1: cbNIPT detected all aberrations (32/32) found in CVS: trisomies 13, 18 and 21 (23/23), pathogenic copy number variations (CNVs) (6/6) and sex chromosome aberrations (3/3). cbNIPT detected 3/8 cases of mosaicism in the placenta. Study 2: cbNIPT detected all trisomies found with cfNIPT (6/6) and had no false positive (0/246). One of the three CNVs called by cbNIPT was confirmed by CVS but was undetected by cfNIPT, two were false positives. cbNIPT detected mosaicism in five samples, of which two were not detected by cfNIPT. cbNIPT failed in 7.8% compared to 2.8% in cfNIPT. Conclusion: Circulating trophoblasts in the maternal circulation provide the potential of screening for aneuploidies and pathogenic CNVs covering the entire fetal genome. Key points: What is already known about this topic? Circulating fetal trophoblasts can be isolated from maternal circulation and whole genome amplified DNA can be obtained.Case studies have demonstrated its use in detecting aneuploidies, copy number variations (CNVs) and monogenic disorders. What does this study add? This is the first clinical validation study reporting high sensitivity and specificity for aneuploidies and likely also for CNVs over the entire genome.Known microdeletion/duplication syndromes as well as unique disease causing CNVs >1 MB can be reliably detected. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01973851
Volume :
43
Issue :
7
Database :
Complementary Index
Journal :
Prenatal Diagnosis
Publication Type :
Academic Journal
Accession number :
164587569
Full Text :
https://doi.org/10.1002/pd.6387